MEDIFAST (MED)
(Delayed Data from NYSE)
$18.60 USD
-0.23 (-1.22%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $18.58 -0.02 (-0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$18.60 USD
-0.23 (-1.22%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $18.58 -0.02 (-0.11%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Sysco's (SYY) Latest Move to Enhance Delivery to Aid Growth
by Zacks Equity Research
Sysco (SYY) and Daimler Truck North America unveil a Letter of Intent to allocate up to around 800 battery electric Freightliner eCascadia Class 8 tractors to cater to Sysco's U.S. customers by 2026.
Kimberly-Clark's (KMB) Saving Efforts Aid Amid Rising Costs
by Zacks Equity Research
Kimberly-Clark's (KMB) efficient cost-saving efforts are yielding amid rising input costs. Also, the company is committed to its three key strategic growth pillars.
Service Corporation (SCI) Stock Appears Promising: Here's Why
by Zacks Equity Research
Service Corporation (SCI) has been gaining on its robust Funeral segment sales and its focus on expansion.
Mondelez (MDLZ) Troubled by Cost Inflation, Supply-Chain Woes
by Zacks Equity Research
Mondelez (MDLZ) has been encountering inflation in input costs and supply-chain bottlenecks. Management cuts its EPS growth forecast due to cost inflation.
Tyson Foods (TSN) Gains on Solid Brands & Capacity-Expansion
by Zacks Equity Research
Tyson Foods (TSN) is undertaking several operational and supply chain efficiency programs to place itself better for the long run.
Zacks.com featured highlights include Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA
by Zacks Equity Research
Imperial Oil, CF Industry Holdings, The Chemours, Medifast, and APA are part of Screen of the Week article.
Sysco (SYY) Looks Promising: Stock Up More Than 10% in 6 Months
by Zacks Equity Research
Sysco Corporation (SYY) has been gaining on its Recipe for Growth plan and solid food-away-from-home trends.
5 High Earnings Yield Value Picks Amid Market Jitters
by Rimmi Singhi
Value investing should be one of the most effective investment approaches now. IMO, CF, CC, MED and APA are some high earnings yield value stocks to tide over market mayhem.
McCormick (MKC) Stock Up More Than 15% in 6 Months: Here's Why
by Zacks Equity Research
McCormick (MKC) is benefiting from a robust recovery in the away-from-home demand. The company's prudent buyouts are yielding.
Are Investors Undervaluing MEDIFAST (MED) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
B&G Foods (BGS) Troubled by Cost Inflation, Supply-Chain Woes
by Zacks Equity Research
B&G Foods (BGS) has been encountering industry-wide inflation in input costs and supply-chain bottlenecks. Management cuts its adjusted EBITDA and EPS forecast due to cost inflation.
General Mills (GIS) TNT Crust Buyout to Fuel Accelerate Strategy
by Zacks Equity Research
General Mills (GIS) to acquire TNT Crust by first-quarter fiscal 2023. The move fortifies the company's position in the fast-growing away-from-home frozen baked goods category.
Mondelez (MDLZ) Growth Strategy Includes Portfolio Focus & More
by Zacks Equity Research
Mondelez International (MDLZ) updates the progress of its long-term strategy on its Investor Day. Also, the company updates its long-term organic net revenue growth algorithm to 3-5%.
3 Reasons Why Medifast (MED) Is a Great Growth Stock
by Zacks Equity Research
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Medifast (MED) Tops Q1 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Medifast's (MED) first-quarter 2022 results reflect increased earnings and revenues owing to continued strength in OPTAVIA. Management raises sales and earnings view for 2022.
Medifast (MED) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 0.84% and 0.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Things to Note as Medifast (MED) Lines Up for Q1 Earnings
by Zacks Equity Research
Medifast's (MED) first-quarter results are likely to reflect gains from the OPTAVIA lifestyle solution and coaching support system, whereas high costs are a concern.
Conagra Brands (CAG) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Conagra Brands (CAG) delivered earnings and revenue surprises of 1.75% and 2.74%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Medifast (MED) Troubled by High SG&A Costs, Gross Margin Woes
by Zacks Equity Research
Medifast (MED) has been seeing high SG&A expenses for a while now, mainly due to higher OPTAVIA commission costs. The company's gross margin has also been under pressure.
Sprouts Farmers (SFM) Q4 Earnings Beat, Sales Decline Y/Y
by Zacks Equity Research
Sprouts Farmers' (SFM) fourth-quarter 2021 comparable store sales decline 1.1% year over year. For 2022, management forecast comparable store sales growth to be 0-2%.
Keurig Dr Pepper (KDP) Q4 Earnings In Line, Sales Surpass
by Zacks Equity Research
Keurig Dr Pepper's (KDP) Q4 results gain from solid consumer demand and improvement in the away-from-home channel. Management issues an upbeat 2022 view.
Beyond Meat (BYND) Q4 Loss Wider Than Expected, Stock Down
by Zacks Equity Research
Beyond Meat's (BYND) fourth-quarter 2021 results reflect lower sales and a wider loss compared with the year-ago period. Soft U.S. retail demand due to the pandemic is a downside.
Medifast (MED) Q4 Earnings Beat, Strength in OPTAVIA Key Driver
by Zacks Equity Research
Medifast's (MED) fourth-quarter 2021 results reflect stellar earnings and revenues, courtesy of continued strength in OPTAVIA. Sales and earnings view for 2022 reflect year-over-year growth.
Medifast (MED) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 8.99% and 0.49%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Mondelez (MDLZ) Outlines Growth Strategy for AMEA Region
by Zacks Equity Research
Mondelez International (MDLZ) outlines its strategy for the Asia Pacific, Middle East & Africa region at the CAGNY Conference. It has core strategies designed to fuel sustainable growth there.